AbbVie's Allergan Aesthetics Receives FDA Approval For SKINVIVE By JUVÉDERM To Reduce Neck Lines To Enhance Neck Appearance In Adults Over Age 21
Express News | Allergan Aesthetics Receives U.S. FDA Approval for Skinvive by Juvéderm® for the Improvement of Neck Appearance
5 Powerhouse Dividend Stocks With Huge Cash Payouts to Help Investors Crush Surging Inflation
AbbVie Targets Pediatric AML With New Pivekimab Sunirine Trial, Signaling Deeper Oncology Push
AbbVie Targets Tough Pancreatic Cancer With New Phase 2/3 Telisotuzumab Study
AbbVie Says Nine-Year Data Reinforces Venetoclax Benefit In Leukemia Patients
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Citi Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $230
AbbVie (ABBV) Receives a Hold From Citi
AbbVie Says Leukemia Combination Therapy Shows Long-Term Benefit Phase 3 Study
Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV)
Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $275
Morgan Stanley, Shake Shack, Cboe Global Markets And A Health Care Stock On CNBC's 'Final Trades'
AbbVie (ABBV) Receives a Hold From Bernstein
HHS Indicates Skepticism on International Cancer Risk Assessments
AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), GMR Solutions, Inc. Class A (GMRS) and Cullinan Management (CGEM)
UnitedHealth, Eli Lilly Lead Healthcare Rankings as Sector Gains Momentum
Unusual Options Activity: IOT, GLXY and Others Attract Market Bets, IOT V/OI Ratio Reaches 96.9
EST Jun 4th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
AbbVie Advances ABBV-932 With Completed Bioavailability Study, Supporting Long-Term Pipeline Value